Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 3 of 3
Full-Text Articles in Medicine and Health Sciences
All-Cause And Cause-Specific Mortality Among Medicaid-Insured Women With Preexisting Type 2 Diabetes Mellitus Diagnosed With Breast Cancer : An Epidemiological Analysis Of Linked New York State Medicaid And Cancer Registry Data, Wayne Rashaan Lawrence
Legacy Theses & Dissertations (2009 - 2024)
Background: The present study investigated the influence preexisting type 2 diabetes mellitus (T2DM) and antidiabetic drugs have on all-cause and cause-specific mortality among Medicaid-insured women diagnosed with breast cancer by menopausal status.
Spina Bifida Mortality By Clinical And Demographic Characteristics Using The New York State Birth Defects Registry, 2008-2016, Anaclare Mackenzie Sullivan
Spina Bifida Mortality By Clinical And Demographic Characteristics Using The New York State Birth Defects Registry, 2008-2016, Anaclare Mackenzie Sullivan
Legacy Theses & Dissertations (2009 - 2024)
Background: Spina bifida is the most common neural tube defect. It has been associated with increased mortality, disability, and may require lifelong medical care. Few previous studies have assessed the impact that maternal race/ethnicity or variations in clinical features of the disease may have on mortality.
The Burden Of Hepatitis C Virus In New York State, Rachel Hart Malloy
The Burden Of Hepatitis C Virus In New York State, Rachel Hart Malloy
Legacy Theses & Dissertations (2009 - 2024)
Hepatitis C virus (HCV) infection is estimated to be the most common chronic blood-borne infection in the United States (US). Annual incidence of HCV in the US peaked in the late 1980's, declined steadily through the 1990's and has plateaued since 2003 with approximately 18,000 new cases in 2008. The morbidity and mortality associated with HCV is expected to rise until at least 2015. Due to the high rate of asymptomatic cases, inherent limitations with target screening recommendations, limitations with screening technologies and scarce resources for surveillance nationwide, quantification of the burden is difficult. US estimates of disease burden have …